Peer-influenced content. Sources you trust. No registration required. This is HCN.
Annals of Clinical and Translational Neurology (ACTN)
In a specialty-clinic cohort of 2,329 adults with Neuro-PASC, females reported more neurologic symptoms, greater fatigue, and, among nonhospitalized patients, poorer attention than males approximately 16 months after symptom onset.
Infectious Diseases September 28th 2026
News Medical
Prior ayahuasca experience was associated with lower self-reported depression, stress, and alcohol use among Brazilian ceremony participants, while also correlating with stronger spiritual wellbeing and metaphysical beliefs in an observational study that did not establish causality.
Behavioral Health September 25th 2026
Oncology News Central (ONC)
Growing numbers of cancer survivors are prompting renewed discussion about how survivorship services should be delivered, with oncology and palliative care leaders emphasizing symptom management, quality of life, clinician training, and long-term support needs.
Hematology/Oncology September 24th 2026
Psychiatrist.com
A post hoc analysis of five brexpiprazole trials found improved functioning in adults with schizophrenia, including those with baseline hostility or agitation. The exploratory findings require interpretation alongside trial-design limitations and lack of multiplicity adjustment.
Psychiatry August 19th 2026
Epilepsia
The NAUTILUS trial met its primary safety endpoint for responsive centromedian thalamic stimulation in drug-resistant idiopathic generalized epilepsy. The prespecified primary effectiveness endpoint was not significant, while post hoc and 18-month outcomes showed sustained seizure reductions.
Neurology August 5th 2026
ReachMD
In a 3-year randomized clinical trial, dialectical behavior therapy and schema therapy produced substantial improvements in borderline personality disorder severity. No statistically significant differences were observed between treatments on primary or secondary outcomes.
Psychiatry July 31st 2026